| Financial Year |
March 31 2023 |
| Monetary Funds |
33,734,757.88 |
| Held-for-trading Financial Assets |
52,809,182.43 |
| Notes Receivable |
4,003,674.28 |
| Accounts Receivable |
81,293,024.48 |
| Advances to Suppliers |
1,601,645.47 |
| Other Receivables |
10,881,345.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
754,008.57 |
| Dividend Receivable |
-- |
| Inventories |
41,464,873.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
41,862,999.99 |
| Other Current Assets |
20,797,967.36 |
| Total Current Assets |
295,537,711.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
389,490.95 |
| Investment Properties |
-- |
| Fixed Assetes |
165,789,061.16 |
| Under-construction Projects |
102,001,312.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,514,876.68 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,902,635.83 |
| Deferred Income Tax Assets |
2,947,940.77 |
| Other Non-Current Assets |
144,225,808.02 |
| Sub-Total of Non-Current Assets |
440,771,125.52 |
| Total Assets |
736,308,836.58 |
| Short-Term Loans |
10,010,136.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
32,033,833.49 |
| Accounts Payable |
38,698,115.12 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,915,660.79 |
| Taxes Payable |
3,185,262.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,518,116.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
264,047.71 |
| Sub-Total of Current Liabilities |
92,995,737.21 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,954,799.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,954,799.59 |
| Total Liabilities |
94,950,536.80 |
| Paid-In Capital(Or Share Stock) |
84,160,000.00 |
| Capital Surplus |
381,077,913.81 |
| Surplus Reserve |
24,750,723.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
150,457,522.62 |
| Minority Stockholder's Interest |
893,945.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
640,464,354.10 |
| Owner's Equity（Stockholder's Equity） |
641,358,299.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
736,308,836.58 |
